115 related articles for article (PubMed ID: 35909048)
1. Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort.
Zhu Y; Vogelpohl FA; Heiner-Fokkema MR; Pranger IG; Minović I; Navis GJ; Bakker SJL; Riphagen IJ
J Clin Lipidol; 2022; 16(5):658-666. PubMed ID: 35909048
[TBL] [Abstract][Full Text] [Related]
2. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
[TBL] [Abstract][Full Text] [Related]
3. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D
J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385
[TBL] [Abstract][Full Text] [Related]
4. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
[TBL] [Abstract][Full Text] [Related]
5. Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
Qureshi W; Santaren ID; Hanley AJ; Watkins SM; Lorenzo C; Wagenknecht LE
BMJ Open Diabetes Res Care; 2019; 7(1):e000691. PubMed ID: 31543975
[TBL] [Abstract][Full Text] [Related]
6. Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers.
Rosqvist F; McNeil CA; Pramfalk C; Parry SA; Low WS; Cornfield T; Fielding BA; Hodson L
Am J Clin Nutr; 2019 Feb; 109(2):260-268. PubMed ID: 30721918
[TBL] [Abstract][Full Text] [Related]
7. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
[TBL] [Abstract][Full Text] [Related]
8. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.
Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X
Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879
[TBL] [Abstract][Full Text] [Related]
9. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
[TBL] [Abstract][Full Text] [Related]
10. Association between erythrocyte fatty acids in de novo lipogenesis pathway and DXA-derived body fat and trunk fat distribution in Chinese adults: a prospective study.
Zeng FF; Chen ZY; Zheng JS; Lin JS; Li YH; Qiu R; Wang C; Sun LL; Chen YM
Eur J Nutr; 2019 Dec; 58(8):3229-3239. PubMed ID: 30470880
[TBL] [Abstract][Full Text] [Related]
11. De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients.
Bock M; von Schacky C; Scherr J; Lorenz E; Lechner B; Krannich A; Wachter R; Duvinage A; Edelmann F; Lechner K
J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568339
[TBL] [Abstract][Full Text] [Related]
12. Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial.
Costabile G; Della Pepa G; Salamone D; Luongo D; Naviglio D; Brancato V; Cavaliere C; Salvatore M; Cipriano P; Vitale M; Corrado A; Rivellese AA; Annuzzi G; Bozzetto L
Nutrients; 2022 May; 14(10):. PubMed ID: 35631319
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
Wu JH; Lemaitre RN; Manichaikul A; Guan W; Tanaka T; Foy M; Kabagambe EK; Djousse L; Siscovick D; Fretts AM; Johnson C; King IB; Psaty BM; McKnight B; Rich SS; Chen YD; Nettleton JA; Tang W; Bandinelli S; Jacobs DR; Browning BL; Laurie CC; Gu X; Tsai MY; Steffen LM; Ferrucci L; Fornage M; Mozaffarian D
Circ Cardiovasc Genet; 2013 Apr; 6(2):171-83. PubMed ID: 23362303
[TBL] [Abstract][Full Text] [Related]
14. Supplemental palmitoleic (C16:1 cis-9) acid reduces lipogenesis and desaturation in bovine adipocyte cultures.
Burns TA; Duckett SK; Pratt SL; Jenkins TC
J Anim Sci; 2012 Oct; 90(10):3433-41. PubMed ID: 22851248
[TBL] [Abstract][Full Text] [Related]
15. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32188593
[TBL] [Abstract][Full Text] [Related]
16. Effects of Supplemented Mediterranean Diets on Plasma-Phospholipid Fatty Acid Profiles and Risk of Cardiovascular Disease after 1 Year of Intervention in the PREDIMED Trial.
Razquin C; Ruiz-Canela M; Wernitz A; Toledo E; Corella D; Alonso-Gómez Á; Fitó M; Gómez-Gracia E; Estruch R; Fiol M; Lapetra J; Serra-Majem L; Ros E; Arós F; Salas-Salvadó J; Schulze MB; Martinez-Gonzalez MA
Clin Chem; 2023 Mar; 69(3):283-294. PubMed ID: 36683466
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dietary and plasma phospholipid fatty acids between normal weight and overweight black South Africans according to metabolic health: The PURE study.
Ojwang AA; Smuts CM; Zec M; Wentzel-Viljoen E; Kruger IM; Kruger HS
Prostaglandins Leukot Essent Fatty Acids; 2020 Jul; 158():102039. PubMed ID: 31780327
[TBL] [Abstract][Full Text] [Related]
18. Isotope Labeling and Biochemical Assessment of Liver-Triacylglycerol in Patients with Different Levels of Histologically-Graded Liver Disease.
Syed-Abdul MM; Moore MP; Wheeler AA; Ganga RR; Diaz-Arias A; Petroski GF; Rector RS; Ibdah JA; Parks EJ
J Nutr; 2023 Dec; 153(12):3418-3429. PubMed ID: 37774841
[TBL] [Abstract][Full Text] [Related]
19. Association between de novo lipogenesis susceptibility genes and coronary artery disease.
Simons PIHG; Valkenburg O; Stehouwer CDA; Brouwers MCGJ
Nutr Metab Cardiovasc Dis; 2022 Dec; 32(12):2883-2889. PubMed ID: 36182335
[TBL] [Abstract][Full Text] [Related]
20. Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States.
Diffenderfer MR; Rajapakse N; Pham E; He L; Dansinger ML; Nelson JR; Schaefer EJ
J Clin Lipidol; 2022; 16(2):184-197. PubMed ID: 35120898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
